|
|
Article: Cancer Vaccine Research Is Coming To Fruition, With A Number Of Products Now In Phase III Trials And 15 Therapeutic Cancer Vaccines Realistically Expected To Launch By 2013.
- Article from:
- M2 Presswire
- Article date:
- June 11, 2008
|
Copyright informationCOPYRIGHT 2008 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-11 June 2008-Research and Markets: Cancer Vaccine Research Is Coming To Fruition, With A Number Of Products Now In Phase III Trials And 15 Therapeutic Cancer Vaccines Realistically Expected To Launch By 2013(C)1994-2008 M2 COMMUNICATIONS LTD
RDATE:11062008
Dublin - Research and Markets (http://www.researchandmarkets.com/research/3c725b/cancer_vaccine_dev) has announced the addition of the "Cancer Vaccine Developments to 2013 + Cancer Vaccine Tracker" report to their offering.
The launch of Sanofi Pasteur MSD's Gardasil and GSK's Cervarix has propelled cancer vaccines from research obscurity to a key area of commercial and clinical interest. But can ...